220041-33-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(2-AMINO-THIAZOL-4-YL)-ACETAMIDE is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its presence of a thiazole ring and an amino group provides a versatile scaffold for the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-(2-AMINO-THIAZOL-4-YL)-ACETAMIDE is utilized as a key component in the design and synthesis of novel drug candidates. Its unique structural features allow researchers to explore its potential in treating various diseases by modulating biological targets and pathways.
Used in Drug Development:
2-(2-AMINO-THIAZOL-4-YL)-ACETAMIDE is employed in the process of drug development to create new therapeutic agents. Its chemical properties make it a valuable tool for medicinal chemists to optimize the pharmacological properties of drug candidates, such as potency, selectivity, and bioavailability.
Note: The specific applications and industries for 2-(2-AMINO-THIAZOL-4-YL)-ACETAMIDE are not explicitly provided in the materials. The uses listed above are inferred based on the general properties and potential of thiazole derivatives in pharmaceutical chemistry. Further research and development would be required to identify specific applications and industries where 2-(2-AMINO-THIAZOL-4-YL)-ACETAMIDE could be utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 220041-33-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,0,4 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 220041-33:
(8*2)+(7*2)+(6*0)+(5*0)+(4*4)+(3*1)+(2*3)+(1*3)=58
58 % 10 = 8
So 220041-33-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H7N3OS/c6-4(9)1-3-2-10-5(7)8-3/h2H,1H2,(H2,6,9)(H2,7,8)
220041-33-8Relevant academic research and scientific papers
Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
-
Page/Page column 289, (2015/11/16)
The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.
4-Aryl-pyridine-2-carboxyamide derivatives
-
Page/Page column 37, (2010/11/28)
The present invention relates to novel pyridine-2-carboxyamide derivatives of formula (I) useful as metabotropic glutamate receptor antagonists: wherein Y, Z, R1, R2 and R3 are as defined in the specification herein.
2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
-
, (2008/06/13)
PCT No. PCT/SE98/01240 Sec. 371 Date Sep. 30, 1998 Sec. 102(e) Date Sep. 30, 1998 PCT Filed Jun. 25, 1998 PCT Pub. No. WO99/02501 PCT Pub. Date Jan. 21, 1999The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.
